Substance abuse and HIV-gp120: Are opiates protective?

Archivum Immunologiae et Therapiae Experimentalis

Volumn 47, Issue 2, 1999, Pages 99-106

  Stefano, George B ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

gp120; HIV; Immunovascular regulation; Monocytes; Morphine; Nitric oxide

Indexed keywords

ADEFOVIR; ANANDAMIDE; GAMMA INTERFERON; GLYCOPROTEIN GP 120; LIPOPOLYSACCHARIDE; MORPHINE; N ACETYL S NITROSOPENICILLAMINE; NALOXONE; NITRIC OXIDE; OPIATE DERIVATIVE; RIMONABANT; VASCULAR CELL ADHESION MOLECULE 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; CELL INTERACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MONOCYTE; MOUSE; NEEDLESTICK INJURY; NONHUMAN; OPIATE ADDICTION; REVIEW; SUBSTANCE ABUSE; TISSUE INJURY; VIRUS ENVELOPE; VIRUS LOAD;

ANIMALS; HIV ENVELOPE PROTEIN GP120; HUMANS; NARCOTICS; SUBSTANCE-RELATED DISORDERS;

EID: 0032942149     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. ADAMSON D. C., WILDEMANN B., SASAKI M., GLASS J. D., MC ARTHUR J. C., CHRISTOV V. I., DAWSON T. M. and DAWSON V. L. (1996): Immunologic NO synthase: elevation in severe AIDS dementia and the induction by HIV-1 gp41. Science, 274, 1917-1921.
2. BATH P. M. W., HASALL D. G., GLADWIN A. M., PALMER R. M. and MARTIN J. F. (1991): Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endotheliuin in vitro. Arterioscler. Thromb., 11, 254-260.
3. BEVILACQUA M. P. (1993): Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol., 11, 767-804.
4. BHARGAVA H. N. (1995): Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmacol., 26, 1049-1053.
5. BILFINGER T. V., HARTMAN A., LIU Y., MAGAZINE H. I. and STEFANO G. B. (1997): Cryopreserved veins used for myocardial revascularization: a 5 year experience and a possible mechanism for their increased failure. Ann. Thorac. Surg., 63, 1063-1069.
6. BIRDSALL H. H., TRIAL J., HALLUM J. A., DE JONG A. L., GREEN L. K., BANDRES J. C., SMOLE S. C., LAUGHTER A. H. and ROSSEN R. D. (1994): Phenotypic and functional activation of monocytes in HIV-1 infection: interactions with neural cells. J. Leukoc. Biol., 56, 310-317.
7. BRENNEMAN D. E., BUZY J., RUFF M. R. and PERT C. (1988): Peptide T sequences prevent neuronal cell death produced by the envelope protein (gp120) of the human immunodeficiency virus. Drug Dev. Res., 15, 361-369.
8. BRENNEMAN D. E., WESTBROOK G., FITZGERALD S., ENNIST D., ELKINS K., RUFF M. R. and PERT C. (1988): Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature, 335, 639-642.
9. BUKRINSKY M., SCHMIDTMAYEROVA H., ZYBARTH G., DUBROVSKY L., SHERRY B. and ENIKOLOPOV G. (1996): A critical role of nitric oxide in human immunodeficiency virus type 1-induced hyperresporisiveness of cultured monocytes. Mol. Med., 2, 460-468.
10. BURNETTE-CURLEY D. and CABRAL G. A. (1995): Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta-9-tetrahydrocannabinol. Proc. Soc. Exp. Biol. Med., 210, 64-76.
11. CABRAL G. A. and FISCHER-STENGER K. (1994): Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol. Life Sci., 54, 1831-1844.
12. CALIGNANO A., PERSICO P., MANCUSO F. and SORRENTINO L. (1993): Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice. Eur. J. Pharmacol., 321, 415.
13. CHAO C. C., SHARP B. M., POMEROY C., FILICE G. A. and PETERSON P. K. (1990): Lethality of morphine in mice infected with Toxoplasma gondii. J. Pharmacol. Exp. Ther., 252, 605-609.
14. CHAO C. C., SHARP B. M., POMEROY C., FILICE G. A. and PETERSON P. K. (1991): Effects of morphine addiction on the pathogenesis of murine toxoplasmosis. Adv. Exp. Med. Biol., 288, 223-227.
15. CHUANG L. F., KILLAM K. F. JR. and CHUANG R. Y. (1993): Increased replication of simian immunodeficiency virus in CEM × 174 cells by morphine sulfate. Biochem. Biophys. Res. Commun., 195, 1165-1173.
16. DAMBISYA Y. M. and LEE T. L. (1996): Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br. J. Pharmacol., 117, 914-918.
17. DAWSON V. L., DAWSON T. M. and UHL G. R. (1993): Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Adv. Neuroimmunol., 90, 3256-3259.
18. DE CATERINA R., LIBBY P., PENG H. B., THANNICKAL V. J., RAJAVASHISTH T. B., GIMBRONE M. A. JR., SHIN W. S. and LIAO J. K. (1995): Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest., 96, 60-81.
19. DEMBINSKA-KIEC A. ZMUDA A., WENHRYNOWICZ O., STACHURA J., PESKAR B. A. and GRYGLEWSKI R. J. (1993): Selectin-P-mediated adherence of platelets to neutrophils is regulated by prostanoids and nitric oxide. Int. J. Tissue React., 15, 55-64.
20. DEVANE M. A., HANUS L., BREUER A., PERTWEE R. G., STEVENSON L. A., GRIFFIN G., MANDELBAUM A., ETINGER A. and MECHOULAM R. (1992): Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
21. DOBRENIS K., MAKMAN M. H. and STEFANO G. B. (1995): Occurrence of the opiate alkaloid-selective μ3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res., 686, 239-248.
22. DONAHOE R. M. (1993): Neuroimmunomodulation by opiates. Relationship to HIV-1 infection and AIDS. Adv. Neuroimmunol., 3, 31-46.
23. DONAHOE R. M. and VLAHOV D. (1998): Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J. Neuroimmunol., 83, 77-87.
24. DUARTE I. D. and FERREIRA S. H. (1992): The molecular mechanism of central analgesia iduced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol., 221, 171.
25. FECHO K., MASLONEK K. A., COUSSONS-READ M. E., DYKSTRA L. A. and LYSLE D. T. (1994): Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol., 152, 5845.
26. FERREIRA S. H., DUARTE I. D. and LORENZETTI B. B. (1991): The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur. J. Pharmacol., 201, 121.
27. FIMIANI C., MATTOCKS D. W., CAVANI F., SALZET M., DEUTSCH D. G., PRYOR S. C., BILFINGER T. V. and STEFANO G. B. (1999): Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell. Signal. (in press).
28. FONTANA A., KRISTENSEN F., DUBS R. and GEMSA-WEBER E. (1997): Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J. Immunol., 129, 2413-2419.
29. FREI K. C., SIEPL P., GROSCURTH S., BODMER C., SCHWERDEL C. and FONTANA A. (1987): Antigen presentation and tumor cytoxicity by interferon-treated microglia cells. Eur. J. Immunol., 17, 1271-1278.
30. FRIEDMAN M., CEPERO M. L., KLEIN T. and FRIEDMAN H. (1986): Suppressive effect of delta-9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages. Proc. Soc. Exp. Biol. Med., 182, 225-228.
31. GABUZDA D. and HIRSCH M. S. (1987): Neurologic manifestations of infections with human deficiency virus. Clinical features and pathogenesis. Ann. Int. Med., 107, 383-391.
32. GENDELMAN H. E., GENIS P., JETT M., ZHAI Q.-H. and NOTTET L. M. (1994): An experimental model system for HIV-1-induced brain injury. Adv. Neuroimmunol., 4, 189-194.
33. GIULIAN D., BAKER T., SHIH L. C. and LACHMAN L. (1986): Interleukin 1 of the central nervous system is produced by amoeboid microglia. J. Exp. Med., 164, 594-604.
34. GYIRES K. (1994): The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur. J. Pharmacol., 255, 33.
35. HAROUSE J., BHAT S., SPITALNIK S., LAUGHLIN M., STEFANO K., SILBERBERG D. and GONZALEZ-SCARANO F. (1991): Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science, 253, 320-323.
36. HERMANN E., IDZIOREK T., KUSNIERZ J. P., MOUTON Y., CAPRON A. and BAHR G. M. (1997): Role of nitric oxide in the regulation of lymphocyte apoptosis and HIV-1 replication. Int. J. Immunopharmacol., 19, 387-397.
37. HO D., ROTA T. R., SCHOOLEY R., KAPLAN J., DAVIS-ALLEN J., GROOPMAN J., RESNICK L., FELSENSTEIN D., ANDREWS C. and HIRSCH M. S. (1987): Isolation of HTLV-III from CSF and neural tissues of patients with AIDS related neurological syndromes. Ann. Inst. Pasteur/Virol., 38, 137-144.
38. KAISER P., OFFERMAN J. T. and LIPTON S. (1990): Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology, 40, 1757-1761.
39. KENT T. A., HILLMAN G. R., LEVIN H. S., GUINTO F., KAYE A. R. and CASPAR K. (1993): Neuroimaging in HIV infection, A preliminary quantitative MRI study and review of the literature. Adv. Neuroimmunol., 3, 17-28.
40. KOENIG S., GENDELMAN H. E., ORENSTEIN J., DEL CANTO M. C., PEZESHKPOUR G., YUNGBLUTH M., JENOTTA F., AKAS MIT A., MARTIN M. A. and FAUCI A. S. (1986): Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science, 233, 819-836.
41. KOLESNIKOV Y. A., PICK C. G., CISZEWSKA G. and PASTERNAK G. W. (1993): Blockade of tolerance to morphine but not to κ opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci USA, 90, 5162-5166.
42. KUBES P. and GRANGER D. N. (1992): Nitric oxide modulates microvascular permeability. Am. J. Physiol., 262, H611-H615.
43. KUBES P., KANWAR S., NIU X. F. et al. (1993): Nitrix oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J., 7, 1293-1299.
44. KUBES P., KUROSE I. and GRANGER D. N. (1994): NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol., 267, H931-H937.
45. KUBES P., SUZUKI M. M. and GRANGER D. N. (1991): Nitric oxide an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA, 88, 4651-4655.
46. KUROSE I., KUBES P. and WOLF R. (1993): Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ. Res., 73, 164-171.
47. LIEBERMAN A., PITHA P. and SHIN M. (1989): Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide are a neurotropic virus. Proc. Natl. Acad. Sci. USA, 86, 6348-6352.
48. LIPTON S. A. (1996): Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-chennel blockers and nitric oxide-related species. Brain Pathol., 6, 507-517.
49. LIPTON S. A., YEH M. and DREYER E. B. (1994): Update on current models of HIV related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv. Neuroimmunol., 4, 181-188.
50. LIU Y., SHENOUDA D., BILFINGER T. V., STEFANO M. L., MAGAZINE H. I. and STEFANO G. B. (1996): Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res., 722, 125-131.
51. LOPEZ-CEPERO M., FRIEDMAN M., KLEIN T. and FRIEDMAN H. (1986): Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J. Leukoc. Biol., 39, 679-686.
52. LUSCINSKAS F. W. and LAWLER J. (1994): Integrins as dynamic regulators of vascular function. FASEB J., 8, 929-939.
53. MA X. L., LEFER D. A. M. and ZIPKIN R. E. (1993): S-nitroso-N-acetylpenicillamine is a potent inhibitor of neutrophil-endothelial interaction. Endothelium, 3, 32-39.
54. MACLEAN A., WEI X. Q., HUANG F. P., AL-ALEM U. A., CHAN W. L. and LIWEW F. Y. (1998): Mice lacking inducible nitrix-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol., 79, 825-830.
55. MAGAZINE H. I., KING J. M. and SRIVASTAVA K. D. (1996): Protease activated receptors modulate aortic vascular tone. Int. J. Cardiol., 53, S75-80.
56. MAGAZINE H. I., LIU Y., BILFINGER T. V., FRICCHIONE G. L. and STEFANO G. B. (1996): Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J. Immunol., 156, 4845-4850.
57. MAJEED N. H., PRZEWLOCKA B., MACHELSKA H. and PRZEWLOCKI R. (1994): Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology, 33, 189.
58. MAKMAN M. H., BILFINGER T. V. and STEFANO G. B. (1995): Human granulocytes contain an opiate receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol., 154, 1323-1330.
59. MATTOCKS D. W., SALZET M., SALZET B. and STEFANO G. B. (1997): Anandamide-induced conformational changes in leech and mussel immunocytes are mediated by nitrix oxide. Anim. Biol., 6, 73-77.
60. MCCOY K. L., GAINEY D. and CABRAL G. A. (1995): Delta-9-tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther., 273, 1216-1223.
61. MCEVER R. P. (1994): Selections. Curr. Opin. Immunol., 6, 75-84.
62. MERRILL J., KOYANAGI Y. and CHEN I. (1989): Interleukin 1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by HIV-1 binding to CD4 receptor. J. Virol., 63, 4404-4408.
63. MERRIL J., KOYANAGI Y., ZACK J., THOMAS L., MARTIN F. and CHEN I. (1992): Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus typs 1. J. Virol., 66, 2217-2225.
64. MINTZ M. (1994): Clinical comparison of adult and pediatric neuroAIDS. Adv. Neuroimmunol., 4, 207-222.
65. MOLLACE V., COLASANTI M., RODINO P., LAURO G. M. and NISTICO G. (1994): HIV coating gp120 glycoprotein-dependent prostaglandin E2 release by human cultured astrocytoma cells is regulated by nitric oxide formation. Biochem. Biophys. Res. Commun., 203, 87-92.
66. NIU X. F., SMITH C. W. and KUBES P. (1995): Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res., 74, 1133-1140.
67. PETERHANS E. (1997): Reactive oxygen species and nitrix oxide in viral diseases Biol. Trace Elem. Res., 56, 107-116.
68. PETERSON P. K., GEKKER G., HU S., ANDERSON W. R., KRAVITZ F., PORTOGHESE P. S., BALFOUR H. H. and CHAO C. C. (1994): Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunol., 50, 167-175.
69. PETERSON P. K., SHARP B. M., GEKKER G., PORTOGHESE P. S., SANNERUD K. and BALFOUR H. H. (1990): Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS, 4P, 869-873.
70. PIETRAFORTE D., TRITARELLI E., TESTA U. and MINETTI M. (1994): Gp120 HIV envelope glycoprotein increase the production of nitrix oxide in human monocyte-derived macrophages. J. Leukoc. Biol., 55, 175-182.
71. PINEGIN B. V., SAIDOV M. Z., SCHELTSYNA T. L., GABRILOVICH D. I. and KHAITOV R. M. (1993): Peripheral blood neutrophils from HIV-1 infected individuals are armed with factors that cause inhibition of their migration in response to specific antigens. Immunol. Lett., 36, 13-17.
72. POPE M., MARSDEN P. A., COLE E., SLOAN S., FUNG L. S., NING Q., DING J. W., LEIBOWITZ J. L., PHILLIPS M. J. and LEVY G. A. (1998): Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J. Virol., 72, 7084-7090.
73. RADOMSKI M. W., PALMER R. M. J. and MONCADA S. (1987): Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet, 2, 1057-1058.
74. RAO C., ANZIL A. P. and SHER J. P. (1993): The neuropathology of AIDS. A review. Adv. Neuroimmunol., 3, 1-15.
75. SCHWEITZER C., KELLER F., SCHMITT M. P., JAECK D., ADLOFF M., SCHMITT C., ROYER C., KIRN A. and AUBERTIN A. M. (1991): Morphine stimulates HIV replication in primary cultures of human Kupffer cells. Res. Virol., 142, 189-195.
76. SHARARA A. I. PERKINS D. J., MISUKONIS M. A., CHAN S. U., DOMINITZ J. A. and WEINBERG J. B. (1997): Interferon (IFN) -alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects pf IFN-alpha in vivo. J. Exp. Med., 186, 1495-1502.
77. SHRIKANT P., BENOS D. J., TANG L. P. and BENVENISTE E. N. (1996): HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J. Immunol., 156, 1307-1314.
78. SIMON D. I., STAMLER J. S., JARAKI O. et al. (1993): Antiplatelet properties of protein S-nitrosothiols derived from nitrix oxide and endothelium-derived relaxing factor. Arterioscler. Thromb., 13, 791-799.
79. SPECTER S., LANCZ G. and GOODFELLOW D. (1991): Suppression of human macrophage function in vitro by delta-9-tetrahydrocannabmol. J. Leukoc. Biol., 50, 423-426.
80. SPRINGER T. A. (1994): Traffic signals for lymphocyte recirculation and leukocyte emigration. Cell, 67, 301-314.
81. STEFANO G. B. (1998): Autoimmunovascular regulation: morphine stimulated nitric oxide release. J. Neuroimmunol., 83, 70-76.
82. STEFANO G. B., CHRISTENSEN V. B., TONNESEN E., LIU Y., HUGHES T. K. and BILFINGER T. V. (1997): Interleukin 10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence. J. Cardiovasc. Pharmacol., 30, 90-95.
83. STEFANO G. B., DIGENIS A., SPECTOR S., LEUNG M. K., BILFINGER T. V., MAKMAN M. H., SCHARRER B. and ABUMRAD N. N. (1993): Opiatelike substances in an invertebrate, a novel opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc. Natl. Acad. Sci. USA, 90, 11099-11103.
84. STEFANO G. B., HARTMAN A., BILFINGER T. V., MAGAZINE H. I., LIU Y., CASARES F. and GOLIGORSKY M. S. (1995): Presence of the μ3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J. Biol. Chem., 270, 30290-30293.
85. STEFANO G. B., LIU Y. and GOLIGORSKY M. S. (1996): Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J. Biol. Chem., 271, 19238-19242.
86. STEFANO G. B., SALZET M. and BILFINGER T. V. (1998): Chronic exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes. Uncoupling of nitric oxide. J. Cardiovasc. Pharmacol., (in press).
87. STEFANO G. B., SALZET M., MAGAZINE H. I. and BILFINGER T. V. (1998): Antagonist of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J. Cardiovasc. Pharmacol., 31, 813-820.
88. STEFANO G. B., SALZET M., RIALAS C., MATTOCKS D. W., FIMIANI C. and BILFINGER T. V. (1998): Macrophage behavior associated with acute and chronic exposure to HIV gp120, morphine and anandamide: endothelial implications. Int. J. Cardiol., 64, S3-S13.
89. STEFANO G. B., SALZET B. and SALZET M. (1997): Identification and characterization of the leech CNS cannabinoid receptor. Coupling to nitric oxide release. Brain Res., 753, 219-224.
90. STEFANO G. B., SCHARRER B., BILFINGER T. V., SALZET M. and FRICCHIONE G. L. (1996): A novel view of opiate tolerance. Adv. Neuroimmunol., 6, 265-277.
91. STEFANO G. B., SCHARRER B., SMTH E. M., HUGHES T. K., MAGAZINE H. I., BILFINGER T. V., HARTMAN A., FRICCHIONE G. L., LIU Y. and MAKMAN M. H. (1996): Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol., 16, 109-144.
92. STEFANO G. B., SMITH E. M., CADET P. and HUGHES T. K. (1993): HIV gp120 alteration of DAMA and IL-1a-induced chemotaxic responses in human and invertebrate immunocytes. J. Neuroimmunol., 43, 177-184.
93. SUEMATSU M., TAMATANI T., DELANO F. A., MIYASAKA M., FORREST M., SUZUKI H. and SCHMID-SCHONBEIN G. 2. (1994): Microvascular oxidative stress preceding leukocyte activation elicited by in vivo nitrix oxide suppression. Am. J. Physiol., 266, H2410-H2415.
94. TANG J.-L., LANCZ G., SPECTOR S. and BULLOCK H. (1992): Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line, P388D1. Int. J. Immunopharmacol., 14, 253-262.
95. TORRE D. and FERRARIO G. (1996): Immunological aspects of nitrix oxide in HIV-1 infection. Med. Hypotheses, 47, 405-407.
96. VAUPEL D. B., KIMES A. S. and LONDON E. D. (1995a): Comparison of 7-nitroindazole with other nitrix oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology, 118, 361-368.
97. VAUPEL D. B., KIMES A. S. and LONDON E. D. (1995): Nitric oxide synthase inhibitors - preclinical studies of potential use for the treatment of opioid withdrawal. Neuropsychopharmacology, 13, 315-322.
98. WILEY C. A., SCHREIER R., NELSON J., LAMPERT P. and OLDSTONE M. (1986): Cellular localization of human immunodeficiency virus infection within the brains of acquires immunodeficiency syndrome patients. Proc. Natl. Acad. Sci. USA, 83, 7089-7093.
99. XU J. Y. and TSENG L. F. (1995): Nitric oxide cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine and beta-endorphin-induced antinociception in the mouse. J. Pharmacol. Exp. Ther., 274, 8-16.
100. ZHENG Z. M., SPECTOR S. and FRIEDMAN H. (1992): Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int. J. Immunopharmacol., 14, 1445-1452.
101. ZIDEK Z., HOLY A. and FRANKOVA D. (1997): Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl) adenine stimulates cytokine and nitrix oxide production. Eur. J. Pharmacol., 331, 245-252.